Glycogen storage disease type II classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Glycogen storage disease type II}}
{{Glycogen storage disease type II}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{Anmol}}


==Overview==
==Overview==
There is no established system for the classification of [disease name].
Glycogen storage disease type II may be classified according to the age of onset and presence of [[cardiomegaly]] into 2 subtypes including infantile-onset Pompe disease (IOPD) and late-onset Pompe disease (LOPD).
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==
 
Glycogen storage disease type II may be classified according to the age of onset and presence of [[cardiomegaly]] into 2 subtypes:
{|
{|
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Type of GDS 2}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Type of GSD type 2}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Age of onset}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Age of onset}}
|-
|-
| style="background: #DCDCDC; text-align: center;" |'''Infantile-onset Pompe disease (IOPD)'''
| style="background: #DCDCDC; text-align: center;" |'''Infantile-onset Pompe disease (IOPD)'''
| style="background: #F5F5F5;" |Age of onset before 12 months with cardiomyopathy
| style="background: #F5F5F5;" |Age of onset before 12 months with [[cardiomyopathy]]
|-
|-
| style="background: #DCDCDC; text-align: center;" |'''Late-onset Pompe disease (LOPD)'''
| style="background: #DCDCDC; text-align: center;" |'''Late-onset Pompe disease (LOPD)'''
| style="background: #F5F5F5;" |
| style="background: #F5F5F5;" |
*Age of onset before 12 months without cardiomyopathy
*Age of onset before 12 months without [[cardiomyopathy]]
*Age of onset after 12 months
*Age of onset after 12 months
|}
|}

Revision as of 19:17, 8 January 2018

Glycogen storage disease type II Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glycogen storage disease type II from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glycogen storage disease type II classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glycogen storage disease type II classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glycogen storage disease type II classification

CDC on Glycogen storage disease type II classification

Glycogen storage disease type II classification in the news

Blogs on Glycogen storage disease type II classification

Directions to Hospitals Treating Glycogen storage disease type II

Risk calculators and risk factors for Glycogen storage disease type II classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Glycogen storage disease type II may be classified according to the age of onset and presence of cardiomegaly into 2 subtypes including infantile-onset Pompe disease (IOPD) and late-onset Pompe disease (LOPD).

Classification

Glycogen storage disease type II may be classified according to the age of onset and presence of cardiomegaly into 2 subtypes:

Type of GSD type 2 Age of onset
Infantile-onset Pompe disease (IOPD) Age of onset before 12 months with cardiomyopathy
Late-onset Pompe disease (LOPD)
  • Age of onset before 12 months without cardiomyopathy
  • Age of onset after 12 months

References

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Glycogen_storage_disease_type_II_classification&oldid=1428570"